Sara Iannuzzi
Biographic Data
| ID | 7768211 |
|---|---|
| NAME | Sara Iannuzzi |
| GIVEN NAMES | Sara |
| FAMILY NAME | Iannuzzi |
| SIGNATURE | IANNUZZI S |
| AFFILIATIONS | Robert Koch Institute |
| ORCID | 0009-0003-3704-5931 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Analysis of potential barriers for PrEP non-users among PrEP-eligible MSM in Germany
Dynamics of HIV PrEP use and coverage during and after Covid-19 in Germany
Our approach presents a comprehensive solution to monitor and forecast PrEP implementation from anonymous data and highlighted that the COVID-19 pandemic significantly decelerated PrEP uptake in Germany. Moreover, slow PrEP uptake in rural areas indicate that structural barriers in PrEP care, education or information exist that may hamper the goal of ending the AIDS epidemic by 2030
No prominent works on this page.
Dynamics of HIV PrEP use and coverage during and after Covid-19 in Germany
Our approach presents a comprehensive solution to monitor and forecast PrEP implementation from anonymous data and highlighted that the COVID-19 pandemic significantly decelerated PrEP uptake in Germany. Moreover, slow PrEP uptake in rural areas indicate that structural barriers in PrEP care, education or information exist that may hamper the goal of ending the AIDS epidemic by 2030
Analysis of potential barriers for PrEP non-users among PrEP-eligible MSM in Germany
Biostatistics (2 works) · Epidemiology (2 works) · Public health (2 works) · Antiretroviral therapy (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · Emtricitabine (1 work) · Family medicine (1 work) · Health services research (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · HIV, Drug Use, Sexual Risk (1 work)